CBD Market
Stirling CBD to launch first CBGA and CBDA water soluble products
The announcement comes after the release of two groundbreaking studies on the effects of CBGA and CBD
Caroline Barry
January 25, 2022
The announcement comes after the release of two groundbreaking studies on the effects of CBGA and CBD
Government funding aims to provide new biomass options for energy including hemp production
Capital raises in cannabis exceed pre-pandemic levels to $10+ billion Cannabis industry capital raises exceeded pre-pandemic levels in 2021, with
Researchers have published more than 3,800 cannabis-related papers so far this year, according to the National Organization for the Reform
Dalriada will support the company with R&D activities.
The company has signed a new agreement with Oxford-based StemTech.
Health House is carrying out a study on its own-branded cannabis extracts.
Piauhy Labs will study the efficacy of cannabinoids for the treatment of diseases such as autism, epilepsy and Alzheimer’s.
Linneo Health has had its GMP certification renewed for its quality control laboratory and its post-harvest facility.
DiArcangelo entered into medical cannabis following a personal experience with a loved one.
In this article, Christopher Tasker, CEO of Global Cannabinoid Solutions, discusses how science can help your cannabis business.
The development will give hope to cancer patients as current treatment options for cancer-related pain are largely ineffective.
BioHarvest Sciences says the groundbreaking structure is instrumental in the ability to grow trichome cells in bioreactors at scale.
Cleaver Leaves has announced it will be supporting The University of Missouri by providing CBD isolate at no cost. Clever
The compound was selected based on a wide-ranging screen of derivatives of CBD and CBG made by cannabis pioneer Professor Mechoulam.
MGC Pharma is hoping to bring more surprises to the market in the next few years.
The agreements follow its post-IPO review after its £16.5m fundraise and admission to the main market on LSE in May this year.
India Globalization hopes the formula could provide relief for the potential 50 million people across the globe which are expected to be impacted by Alzheimer’s disease by 2030
We won’t spam you